TherapeuticsMD, Inc.
TXMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,918 | $23,492 | $50,467 | $143,280 |
| - Cash | $5,059 | $4,327 | $38,067 | $64,907 |
| + Debt | $7,175 | $8,005 | $8,759 | $197,693 |
| Enterprise Value | $12,034 | $27,170 | $21,159 | $276,066 |
| Revenue | $1,761 | $1,302 | $69,963 | $2,573 |
| % Growth | 35.3% | -98.1% | 2,619.1% | – |
| Gross Profit | $1,761 | $1,302 | $68,566 | $1,171 |
| % Margin | 100% | 100% | 98% | 45.5% |
| EBITDA | -$2,983 | -$8,085 | $11,863 | -$70,841 |
| % Margin | -169.4% | -620.9% | 17% | -2,753.2% |
| Net Income | -$2,181 | -$10,278 | $111,997 | -$172,415 |
| % Margin | -123.9% | -789.4% | 160.1% | -6,700.9% |
| EPS Diluted | -0.19 | -0.74 | -10.35 | -25.83 |
| % Growth | 74.3% | 92.9% | 59.9% | – |
| Operating Cash Flow | $732 | -$48,141 | -$4,078 | -$147,811 |
| Capital Expenditures | $0 | $48,141 | -$355 | -$34 |
| Free Cash Flow | $732 | $0 | -$4,433 | -$147,845 |